Total Payments
$11,733
2024 Payments
$3,524
Companies
31
Transactions
638
Medicare Patients
755
Medicare Billing
$56,711
Payment Breakdown by Category
Food & Beverage$11,733 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,733 | 638 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,383 | 120 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,585 | 107 | $0 (2024) |
| Celgene Corporation | $1,197 | 96 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,105 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $1,098 | 41 | $0 (2024) |
| Ardelyx, Inc. | $632.43 | 32 | $0 (2024) |
| PFIZER INC. | $578.95 | 37 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $318.26 | 19 | $0 (2024) |
| Lilly USA, LLC | $313.61 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $285.40 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,524 | 182 | ABBVIE INC. ($588.04) |
| 2023 | $3,485 | 186 | Janssen Biotech, Inc. ($579.10) |
| 2022 | $2,777 | 155 | ABBVIE INC. ($732.89) |
| 2021 | $1,948 | 115 | AbbVie Inc. ($574.94) |
All Payment Transactions
638 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $30.63 | General |
| Category: Rare Disease | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Gastroenterology | ||||||
| 11/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: GI | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.28 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 297 | 339 | $71,707 | $20,898 |
| 2022 | 5 | 178 | 197 | $38,436 | $12,937 |
| 2021 | 4 | 179 | 211 | $38,915 | $15,758 |
| 2020 | 2 | 101 | 118 | $19,370 | $7,119 |
Total Patients
755
Total Services
865
Medicare Billing
$56,711
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 113 | $28,589 | $9,316 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 96 | $17,952 | $5,614 | 31.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $11,633 | $3,313 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,584 | $1,883 | 28.6% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 39 | 39 | $5,850 | $757.86 | 13.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 16 | 25 | $1,100 | $12.85 | 1.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 93 | $14,524 | $5,195 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 55 | $13,340 | $4,945 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,092 | $1,490 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,533 | $863.57 | 34.1% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 21 | 21 | $2,948 | $442.77 | 15.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 122 | $17,080 | $7,087 | 41.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $9,860 | $3,884 | 39.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 40 | $9,200 | $3,865 | 42.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,775 | $921.47 | 33.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 99 | $13,860 | $4,913 | 35.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $5,510 | $2,206 | 40.0% |
About Brian Clancy
Brian Clancy is a Physician Assistant healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1083151898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Clancy has received a total of $11,733 in payments from pharmaceutical and medical device companies, with $3,524 received in 2024. These payments were reported across 638 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($11,733).
As a Medicare-enrolled provider, Clancy has provided services to 755 Medicare beneficiaries, totaling 865 services with total Medicare billing of $56,711. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Fairfield, CT
- Active Since 01/31/2017
- Last Updated 03/21/2017
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1083151898
Products in Payments
- ZEPOSIA (Drug) $1,163
- XIFAXAN (Drug) $1,102
- ENTYVIO (Biological) $852.94
- RINVOQ (Biological) $705.21
- IBSRELA (Drug) $632.43
- SKYRIZI (Biological) $620.98
- REMICADE (Biological) $533.14
- HUMIRA (Biological) $526.13
- XELJANZ (Drug) $509.69
- TRULANCE (Drug) $483.11
- DUPIXENT (Biological) $366.01
- ZENPEP (Drug) $334.31
- STELARA (Biological) $331.65
- Linzess (Drug) $318.26
- OMVOH (Drug) $256.76
- TREMFYA (Drug) $233.44
- IQIRVO (Drug) $227.53
- CREON (Drug) $213.30
- OCALIVA (Drug) $211.57
- LINZESS (Drug) $210.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fairfield
Marina Mathew, Pa-C, PA-C
Physician Assistant — Payments: $16,765
Physician Assistant $16,765
Emily Roman, Pa-C, PA-C
Physician Assistant — Payments: $10,561
Physician Assistant $10,561
Miss. Emily Knowlton, Pa, PA
Physician Assistant — Payments: $9,660
Physician Assistant $9,660
Hanna Massee, Pa-C, PA-C
Physician Assistant — Payments: $8,605
Physician Assistant $8,605
Imran Mridha, Pa, PA
Physician Assistant — Payments: $8,356
Physician Assistant $8,356
Amanda Kalfas, Pa-C, PA-C
Physician Assistant — Payments: $7,002
Physician Assistant $7,002